Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AM1030 in Atopic Dermatitis
NCT02379910Phase 2Completed
- Sponsor
- AnaMar
- Start
- Nov 2014
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of AM1030 in atopic dermatitis (AD), sponsored by AnaMar. Started Nov 2014; status: completed.
02
Drugs
AM1030
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT02379910.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02379910.